Association of oxidative stress with erectile dysfunction in community-dwelling men and men on dialysis

References

• NIH Consensus Conference. Impotence. NIH consensus development panel on impotence. JAMA. 1993;270:83–90.
   PubMedGoogle Scholar
• Isidori AM, Giammusso B, Corona G, et al. Diagnostic and therapeutic workup of erectile dysfunction: results from a Delphi consensus of andrology experts. Sex Med. 2019;7:292–302.
   PubMed Web of Science ®Google Scholar
• Kessler A, Sollie S, Challacombe B, et al. The global prevalence of erectile dysfunction: a review. BJU Int. 2019;124(4):587–599.
   PubMed Web of Science ®Google Scholar
• Collin F. Chemical basis of reactive oxygen species reactivity and involvement in neurodegenerative diseases. IJMS. 2019;20(10):2407.
   Google Scholar
• Shaito A, Aramouni K, Assaf R, et al. Oxidative Stress-Induced endothelial dysfunction in cardiovascular diseases. Front Biosci. 2022;27(3):105.
   PubMed Web of Science ®Google Scholar
• Guzik TJ, Touyz RM. Oxidative stress, inflammation, and vascular aging in hypertension. Hypertension. 2017;70:660–667.
   PubMed Web of Science ®Google Scholar
• Jabarpour M, Rashtchizadeh N, Argani H, et al. The impact of dyslipidemia and oxidative stress on vasoactive mediators in patients with renal dysfunction. Int Urol Nephrol. 2019;51(12):2235–2242.
   PubMed Web of Science ®Google Scholar
• Defeudis G, Mazzilli R, Tenuta M, et al. Erectile dysfunction and diabetes: a melting pot of circumstances and treatments. Diabetes Metab Res Rev. 2022;38:e3494.
   PubMed Web of Science ®Google Scholar
• Rani V, Deep G, Singh RK, et al. Oxidative stress and metabolic disorders: pathogenesis and therapeutic strategies. Life Sci. 2016;148:183–193.
   PubMed Web of Science ®Google Scholar
• Leisegang K, Roychoudhury S, Slama P, et al. The mechanisms and management of age-related oxidative stress in male hypogonadism associated with non-communicable chronic disease. Antioxidants. 2021;10(11):1834.
   Web of Science ®Google Scholar
• Shukla N, Rossoni G, Hotston M, et al. Effect of hydrogen sulphide-donating sildenafil (ACS6) on erectile function and oxidative stress in rabbit isolated corpus cavernosum and in hypertensive rats. BJU Int. 2009;103(11):1522–1529.
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhou B, Yu Z, et al. Baicalein alleviates erectile dysfunction associated with Streptozotocin-Induced type I diabetes by ameliorating endothelial nitric oxide synthase dysfunction, inhibiting oxidative stress and fibrosis. J Sex Med. 2020;17:1434–1447.
   PubMed Web of Science ®Google Scholar
• Wu XJ, Shen WH, He P, et al. Telomerase reverse transcriptase genetically modified adipose tissue derived stem cells improves erectile dysfunction by inhibiting oxidative stress and enhancing proliferation in rat model. Biomed Pharmacother. 2017;92:595–605.
   PubMed Web of Science ®Google Scholar
• Muniz JJ, Leite LN, De Martinis BS, et al. Chronic ethanol consumption induces erectile dysfunction: role of oxidative stress. Life Sci. 2015;141:44–53.
   PubMed Web of Science ®Google Scholar
• Huang M, Zheng L, Xu H, et al. Oxidative stress contributes to vascular calcification in patients with chronic kidney disease. J Mol Cell Cardiol. 2020;138:256–268.
   PubMed Web of Science ®Google Scholar
• Dounousi E, Papavasiliou E, Makedou A, et al. Oxidative stress is progressively enhanced with advancing stages of CKD. Am J Kidney Dis. 2006;48(5):752–760.
   PubMed Web of Science ®Google Scholar
• Oberg BP, McMenamin E, Lucas FL, et al. Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int. 2004;65(3):1009–1016.
   PubMed Web of Science ®Google Scholar
• Himmelfarb J, Stenvinkel P, Ikizler TA, et al. The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int. 2002;62(5):1524–1538.
   PubMed Web of Science ®Google Scholar
• Gaither TW, Awad MA, Osterberg EC, et al. The natural history of erectile dysfunction after prostatic radiotherapy: a systematic review and meta-analysis. J Sex Med. 2017;14(9):1071–1078.
   PubMed Web of Science ®Google Scholar
• Candy B, Jones L, Williams R, et al. Phosphodiesterase type 5 inhibitors in the management of erectile dysfunction secondary to treatments for prostate cancer: findings from a Cochrane systematic review. BJU Int. 2008;102(4):426–431.
   PubMed Web of Science ®Google Scholar
• Payne RB, Little AJ, Williams RB, et al. Interpretation of serum calcium in patients with abnormal serum proteins. Br Med J. 1973;4(5893):643–646.
   PubMedGoogle Scholar
• Marks LS, Mazer NA, Mostaghel E, et al. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial. JAMA. 2006;296(19):2351–2361.
   PubMed Web of Science ®Google Scholar
• Jenkinson C, Coulter A, Wright L. Short form 36 (SF36) health survey questionnaire: normative data for adults of working age. BMJ. 1993;306(6890):1437–1440.
   PubMed Web of Science ®Google Scholar
• Soma O, Hatakeyama S, Imai A, et al. Relationship between frailty and lower urinary tract symptoms among community-dwelling adults. Low Urin Tract Symptoms. 2020;12(2):128–136.
   PubMed Web of Science ®Google Scholar
• Rosen RC, Cappelleri JC, Smith MD, et al. Development and evaluation of an abridged, 5-item version of the international index of erectile function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res. 1999;11(6):319–326.
   PubMed Web of Science ®Google Scholar
• Alwaal A, Awad M, Boggs N, et al. Sexual health inventory for men questionnaire as a screening method for erectile dysfunction in a general urology clinic. Sex Med. 2020;8(4):660–663.
   PubMed Web of Science ®Google Scholar
• Valavanidis A, Vlachogianni T, Fiotakis C. 8-hydroxy-2' -deoxyguanosine (8-OHdG): a critical biomarker of oxidative stress and carcinogenesis. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2009;27(2):120–139.
   PubMed Web of Science ®Google Scholar
• Sivaratnam L, Selimin DS, Abd Ghani SR, et al. Behavior-related erectile dysfunction: a systematic review and meta-analysis. J Sex Med. 2021;18(1):121–143.
   PubMed Web of Science ®Google Scholar
• Aldemir M, Okulu E, Neşelioğlu S, et al. Evaluation of serum oxidative and antioxidative status in patients with erectile dysfunction. Andrologia. 2012;44(Suppl 1):266–271.
   PubMed Web of Science ®Google Scholar
• Yasuda M, Ide H, Furuya K, et al. Salivary 8-OHdG: a useful biomarker for predicting severe ED and hypogonadism. J Sex Med. 2008;5(6):1482–1491.
   PubMed Web of Science ®Google Scholar
• Ciftci H, Yeni E, Savas M, et al. Paraoxonase activity in patients with erectile dysfunction. Int J Impot Res. 2007;19(5):517–520.
   PubMed Web of Science ®Google Scholar
• Yang S, Giovannucci E, Bracken B, et al. Association between plasma fluorescent oxidation products and erectile dysfunction: a prospective study. BMC Urol. 2015;15:85.
   PubMed Web of Science ®Google Scholar
• El-Assmy A. Erectile dysfunction in hemodialysis: a systematic review. World J Nephrol. 2012;1(6):160–165.
   PubMedGoogle Scholar
• Yeni E, Gulum M, Selek S, et al. Comparison of oxidative/antioxidative status of penile corpus cavernosum blood and peripheral venous blood. Int J Impot Res. 2005;17(1):19–22.
   PubMed Web of Science ®Google Scholar